Tenax Therapeutics, Inc. · NASDAQ:TENX
Logos Global Management LP reported a 9.90% stake in Tenax Therapeutics, Inc. (Schedule 13G)
Event Feb 27, 2026 · Filed Mar 9, 2026
Logos Global Management LP reported a 9.90% stake in Tenax Therapeutics, Inc., 615,000 shares, as a passive investor on Feb 27, 2026. Filed Mar 9, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 615,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Logos Global Management LP | 9.90% | 615,000 |
| Logos Global Management GP LLC | 9.90% | 615,000 |
| Logos Global Master Fund LP | 9.90% | 615,000 |
| Logos GP LLC | 9.90% | 615,000 |
| Arsani William | 9.90% | 615,000 |
Source
Related
- Tenax Therapeutics, Inc.
- Logos Global Management LP
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Logos Global Management LP · May 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026